Purchase Order W81K0023P0091
Award Date 10/1/23
Potential Completion Date 9/30/28
Potential Value $2M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $31,230 delivery order to Roche Diagnostics Corporation for customized reagents and consumables on September 2, 2025. This firm fixed price contract, which serves as a child order under a larger contract vehicle, will be performed in Castleton, Indiana. The award carries no set-aside designation, reflecting open competition in the federal marketplace. Roche Diagnostics Corporation, a foreign-owned manufacturer specializing in in vitro diagnostics and...
- The Defense Health Agency awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation for reagents, with a ceiling value of $10,715.94. This is a child contract under a larger indefinite delivery vehicle, representing a single delivery order against an existing BPA. The award, made on November 14, 2025, carries an ultimate completion date of September 30, 2026, with performance taking place at Roche's facility in Castleton, Indiana. No set-aside...
- The Defense Health Agency awarded a $69,865.08 firm fixed-price purchase order to Roche Diagnostics Corporation for H and E stainer and reagents machinery, with performance at Fort Moore, Georgia and an ultimate completion date of September 30, 2026. This contract was awarded without set-aside designation, reflecting open competition. Roche Diagnostics Corporation, a foreign-owned diagnostic solutions manufacturer headquartered in Indianapolis, Indiana, specializes in in vitro diagnostics,...
- The Defense Health Agency awarded a Blanket Purchase Agreement call valued at $182,375.48 to Roche Diagnostics Corporation for chemistry analyzer and reagents on a cost-per-reportable-result basis. This child contract, issued February 1, 2026, with an ultimate completion date of May 31, 2026, will be performed in Castleton, Indiana. The award was made without set-aside designation, indicating open competition. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in...
- The Defense Health Agency (DHA) awarded a delivery order valued at approximately $1.95 million to Roche Diagnostics Corporation for reagents, supplies, training, and maintenance services supporting a government-owned Roche Diagnostic Total Laboratory Automation system. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, Indiana, specializes in in vitro diagnostic instruments, reagents, and clinical laboratory technologies. The delivery order is firm...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic equipment and reagents, has been awarded a delivery order valued at $722,715.31 by the Defense Health Agency for an Automated Core Lab. The order is firm fixed price with no set-aside designation and is scheduled for completion by September 30, 2025. The work will be performed in Castleton, Indiana, and represents a child contract—indicating it derives from a larger contract vehicle, likely one of Roche's...
- The Defense Health Agency awarded a $147,897.25 firm fixed-price delivery order to Roche Diagnostics Corporation for consumables delivery, with a completion date of January 30, 2026. The delivery order, which represents a child contract with no set-aside designation, will be performed in Castleton, Indiana. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, specializes in in vitro diagnostic solutions, laboratory instruments, and reagents for clinical...
- The Defense Health Agency awarded a BPA call valued at $332,471.70 to Roche Diagnostics Corporation for immunology and coagulation reagents, kits, and consumables. This contract was executed under an existing Blanket Purchase Agreement and represents a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. The award carries no set-aside designation, indicating open competition for the procurement. Roche Diagnostics Corporation, headquartered in Indianapolis, Indiana,...
- The Defense Health Agency (DHA) awarded a delivery order to Roche Diagnostics Corporation for the provision of Roche test reagents in Fiscal Year 2025. This delivery order, designated as Option III, covers the period from October 1, 2024, through September 30, 2025, with a ceiling value of $295,532.69 under a firm fixed-price contract type. The award was made on October 1, 2024, with performance taking place in Castleton, Indiana. No set-aside designation was applied to this contract award. This...
- The Defense Health Agency awarded a delivery order valued at $482,006 to Roche Diagnostics Corporation for chemistry and immunoassay laboratory testing services on a cost-per-reportable-result basis. This non-set-aside contract, effective May 1, 2022, through April 1, 2023, will be performed at Roche's facility in Castleton, Indiana. The award utilizes firm fixed-price pricing under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration schedule, enabling the federal...